CPT-157633 |
Catalog No.GC62909 |
CPT-157633, un dérivé de difluoro-phosphonométhyl phénylalanine, et est un inhibiteur de PTP1B.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 888213-72-7
Sample solution is provided at 25 µL, 10mM.
CPT-157633, a difluoro-phosphonomethyl phenylalanine derivative, and is a PTP1B inhibitor. CPT-157633 prevents binge drinking-induced glucose intolerance[1].
CPT-157633 (0.2 µg/day; intracerebroventricular infusion) alleviates the hypothalamic inflammation and glucose intolerance induced by binge drinking in rats[1].
[1]. Lindtner C, et, al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med. 2013 Jan 30;5(170):170ra14.
Average Rating: 5
(Based on Reviews and 16 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *